Related Experiment Videos
Intravenous nicardipine: cardiovascular effects and clinical relevance
1Department of Medicine, University of Florida, Gainesville.
Insights
Nicardipine hydrochloride, a unique intravenous dihydropyridine calcium antagonist, effectively treats acute cardiovascular conditions like hypertension and heart failure. Its vasodilatory and cardioprotective effects offer rapid, safe management for various cardiac disorders.
Area of Science:
- Cardiovascular Pharmacology
- Clinical Therapeutics
Background:
- Nicardipine hydrochloride is a novel intravenous dihydropyridine calcium antagonist.
- Its unique chemical structure offers distinct clinical advantages for acute cardiovascular conditions.
Purpose of the Study:
- To evaluate the efficacy and safety of nicardipine hydrochloride in managing acute cardiovascular disorders.
- To highlight its unique properties, including vasodilatory and cardioprotective effects.
Main Methods:
- Clinical evaluation of nicardipine hydrochloride in patients with hypertension, coronary artery disease, and congestive heart failure.
- Assessment of its hemodynamic effects, including afterload reduction and coronary vasodilation.
Main Results:
- Nicardipine effectively reduces myocardial oxygen demand and increases supply in coronary artery disease.
- It improves left ventricular function and coronary blood flow in heart failure.
- Demonstrates efficacy in treating mild to moderate hypertension, alone or combined with other agents.
Conclusions:
- Nicardipine hydrochloride is a valuable therapeutic option for acute cardiovascular conditions due to its unique properties.
- Its favorable safety profile, rapid onset, and short duration of action make it suitable for critical care settings.
Abstract:
Nicardipine hydrochloride is the first intravenous dihydropyridine calcium antagonist to become available in the United States. Its chemical structure makes it unique among its drug class and confers clinically useful properties for the treatment of acute cardiovascular conditions, such as ischemia, hypertension, congestive heart failure, cerebrovascular disease, and related disorders. For patients with coronary artery disease, IV nicardipine reduces myocardial oxygen demand by reducing afterload and increases myocardial oxygen supply through coronary vasodilatation. Preliminary data suggest that nicardipine also has cardioprotective and vascular antispastic effects. Nicardipine has been shown to be effective in the treatment of mild to moderate hypertension both as monotherapy and in combination with other antihypertensive agents. In congestive heart failure, nicardipine enhances left ventricular pumping activity and augments coronary blood flow beyond that required by increased myocardial oxygen consumption. Its lack of major effects on sinoatrial and atrioventricular conduction makes it safe for use in patients with certain types of conduction disturbances. Nicardipine's rapid onset and short duration of action are additional advantages for use in the management of acute cardiovascular disorders.